Amphetamine is produced through chemical reactions that attach an amine group (a nitrogen-containing structure) to a specific carbon backbone derived from a compound closely related to compounds found in essential oils and natural chemistry. The core molecule, with the chemical formula C₉H₁₃N, was first synthesized in 1887 by Romanian chemist Lazăr Edeleanu, though it sat largely ignored until Gordon Alles resynthesized it in 1927 while searching for a cheaper substitute for ephedrine. Today, amphetamine is manufactured both legally by pharmaceutical companies under strict federal oversight and illegally in clandestine labs using improvised equipment and dangerous shortcuts.
The Core Chemistry
Amphetamine’s formal chemical name is 1-phenylpropan-2-amine. In plain terms, it’s a small molecule built from a six-carbon ring (the same ring structure found in many organic compounds) connected to a short three-carbon chain with a nitrogen atom attached. In its pure base form, amphetamine is a colorless, volatile liquid with a strong odor and a bitter, burning taste. It has a molecular weight of about 135 grams per mole, making it a relatively simple molecule by pharmaceutical standards.
That simplicity is part of why amphetamine can be synthesized through several different chemical routes, and why controlling its production has been such a persistent challenge for regulators.
Primary Synthesis Routes
Two broad approaches have dominated amphetamine production over the decades. The first, and historically most common for illicit manufacturing, centers on a chemical called phenyl-2-propanone (often abbreviated P2P). The second route starts with ephedrine or pseudoephedrine, compounds once widely available in cold medications.
In the P2P method, the key reaction is called reductive amination. P2P is combined with a nitrogen source (such as ammonium formate or formamide) and a reducing agent, which together convert the ketone group on P2P into an amine group. When ammonium formate or formamide serves as the reducing agent, chemists call this specific version the Leuckart reaction. The result is a form of amphetamine, though it requires further purification and often produces a roughly equal mix of the molecule’s two mirror-image forms.
The ephedrine/pseudoephedrine route works differently. These starting materials already contain much of amphetamine’s structure, including the nitrogen atom, so the chemistry involves removing a hydroxyl group (an oxygen-hydrogen pair) rather than adding nitrogen. This pathway was especially popular for methamphetamine production, but the same precursors can be used to produce amphetamine with modified steps.
Why Mirror-Image Forms Matter
Amphetamine has a single point in its structure where atoms can be arranged in two mirror-image configurations, producing what chemists call the d-isomer (dextroamphetamine) and the l-isomer (levoamphetamine). These two forms are chemically identical but behave differently in the body. The d-isomer is roughly four times more potent at triggering dopamine release in the brain, which accounts for most of amphetamine’s focus-enhancing and euphoric effects. The l-isomer is equal to or slightly more potent than the d-form at releasing norepinephrine, which affects heart rate, blood pressure, and alertness.
The synthesis method determines which forms you get. The P2P route produces a 50/50 racemic mixture of both isomers. Pharmaceutical manufacturers who need pure dextroamphetamine or a specific ratio (like the 75/25 mix of d- to l-isomers found in some branded medications) must use additional separation techniques, such as chiral resolution, to isolate the desired form. Smith, Kline and French first marketed pure dextroamphetamine in 1937 under the trade name Dexedrine after developing methods to separate the two isomers.
Pharmaceutical Manufacturing
Legal amphetamine production takes place in facilities that follow Current Good Manufacturing Practice (cGMP) regulations enforced by the FDA. These rules require written procedures for every step of production, from synthesis through purification to final tableting. Every batch must be tested for identity, strength, quality, and purity, and any deviation from the documented process has to be recorded and justified.
After the active compound is synthesized and purified, it’s typically converted into a salt form (most commonly amphetamine sulfate or a mixed amphetamine salt) to make it stable, water-soluble, and suitable for oral dosing. The sulfate salt, for instance, forms crystals with a slightly bitter taste that dissolve in water and decompose at temperatures above 300°C rather than evaporating like the liquid base form.
During tableting, manufacturers monitor weight variation between individual tablets, disintegration time (how quickly a tablet breaks apart), dissolution rate (how fast the drug releases into solution), and mixing uniformity to ensure each pill delivers a consistent dose. These in-process checks happen on samples pulled from each batch throughout production.
Precursor Chemicals and Legal Controls
The DEA has spent decades playing a regulatory game of cat and mouse with illicit amphetamine producers, progressively restricting access to the raw materials needed for synthesis. P2P itself was classified as a Schedule II controlled substance in 1980 after it became the dominant precursor for illegal production throughout the 1970s. When manufacturers switched to making P2P from other chemicals, Congress and the DEA responded by controlling those upstream precursors as well: phenylacetic acid, acetic anhydride, benzyl cyanide, benzaldehyde, and nitroethane all became regulated List I chemicals.
Ephedrine, pseudoephedrine, and phenylpropanolamine received their own strict controls, including purchase limits on cold medications containing these ingredients. As of 2025, the DEA has proposed adding yet another precursor, P2P methyl glycidic acid, to the List I chemical registry after finding it was being used in clandestine labs to manufacture P2P, which was then converted to amphetamine and methamphetamine.
The full list of controlled precursors now runs to more than 40 chemicals, plus common solvents like acetone, ethyl ether, methyl ethyl ketone, and toluene that are tracked at threshold quantities. Handlers of these chemicals must register with the DEA and report suspicious orders or thefts.
Hazards of Illicit Production
Clandestine amphetamine and methamphetamine labs use volatile, corrosive, and toxic chemicals in makeshift setups with no safety controls. Depending on the method, a single lab may contain anhydrous ammonia, hydrochloric or sulfuric acid, metallic lithium, paint thinner, drain cleaners, and camping fuel. The reactions generate hazardous byproducts that contaminate the air, surfaces, and surrounding environment.
Data from the Hazardous Substances Emergency Events Surveillance System shows that fires, explosions, chemical spills, and toxic air releases are common outcomes at these sites. Among people exposed to clandestine lab chemicals, more than half reported respiratory irritation, roughly a third experienced headaches, and about 15% suffered chemical burns. The contamination extends well beyond the lab itself, posing risks to neighbors, children living in the home, and first responders who discover or dismantle the site. Residual chemical contamination can persist on walls, carpets, and ventilation systems long after production stops.